Principles, effectiveness and caveats in screening for cancer

作者: M. Bretthauer , M. Kalager

DOI: 10.1002/BJS.8995

关键词:

摘要: Background: Cancer screening has the potential to prevent or reduce incidence and mortality of target disease, but may also be harmful have unwanted side-effects. Methods: This review explains basic principles cancer screening, common pitfalls in evaluation effectiveness harms summarizes evidence for effects most commonly used tools. Results: Cancer either been established is considered breast, lung, prostate, cervical colorectal cancer. In contrast, gastrointestinal malignancies outside large bowel not generally accepted, available implemented. Oesophageal gastric carcinoma, hepatocellular subject certain risk populations, currently population based on technology. Screening by endoscopy cytology respectively can decrease whereas tools prostate breast detect early-stage invasive disease thus do incidence. Overdiagnosis (detection cancers that will become clinically apparent absence screening) a challenge screening. The improvement quality clinical practice following introduction programmes an appreciated ‘side-effect’, it important disentangle effect from services. As new, powerful tests emerge—particularly molecular genetic fields, radiology other diagnostics–the requirements implementation must borne mind. Conclusion: Cancer several forms Europe. reduction good, exist need addressed, communicated public. Copyright © 2012 British Journal Surgery Society Ltd. Published John Wiley & Sons,

参考文章(58)
, Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. ,vol. 365, pp. 395- 409 ,(2011) , 10.1056/NEJMOA1102873
C. Hery, A. Anttila, L. Voti, N. Segnan, L. von Karsa, P. Autier, M. Boniol, C. Sauvaget, M. Castillo-Beltran, N. Malila, M. Arbyn, J. Ferlay, A. Ponti, G. Ronco, Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening.. ,(2008)
J. Schouten, Europe Against Cancer, N. Perry, European Guidelines for Quality Assurance in Mammography Screening ,(1996)
Consumer Protection, E. Puthaar, N. Perry, European guidelines for quality assurance in breast cancer screening and diagnosis Amendoeira, I; et al (2013). European guidelines for quality assurance in breast cancer screening and diagnosis. Belgium: European Commission.. pp. 1- 160 ,(2013) , 10.5167/UZH-84270
Angela E. Raffle, J. A. Muir Gray, Screening: Evidence and practice ,(2007)
James Maxwell Glover Wilson, Gunnar Jungner, World Health Organization, None, Principles and practice of screening for disease ,(1968)
Peter C Gøtzsche, Karsten Juhl Jørgensen, Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews. ,vol. 2013, ,(2013) , 10.1002/14651858.CD001877.PUB5
Walter W. Holland, Susie Stewart, Screening in Disease Prevention: What Works? ,(2005)
M. Bretthauer, Colorectal cancer screening. Journal of Internal Medicine. ,vol. 270, pp. 87- 98 ,(2011) , 10.1111/J.1365-2796.2011.02399.X
P. W. DICKMAN, H.-O. ADAMI, Interpreting trends in cancer patient survival Journal of Internal Medicine. ,vol. 260, pp. 103- 117 ,(2006) , 10.1111/J.1365-2796.2006.01677.X